Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.25.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Product Revenue
Product Cost of Sales
Gross Income
General and Administrative Expenses 967,833 1,104,130 2,703,815 3,149,041
Research and Development Expenses 356,352 707,747 2,775,337 2,307,789
Stock Based Compensation Expenses 13,762 189,490 973,927
Franchise Tax Expense 200,050 200,050 40,548
Series F-1 Warrant Issuance Expenses 539,097
Series G Warrant Issuance Expenses 969,505
Series H Warrant Issuance Expenses 264,417 264,417
Loss from Operations (1,788,652) (1,825,639) (6,133,109) (7,979,907)
Other (Income) Expenses        
Interest and Dividend Income (35,955) (163,951) (156,042) (203,405)
Gain on Sale of Marketable Securities (551) (2,176) (651)
Change in fair value of Marketable Securities (309) (4,746) 1,435 (3,771)
Change in fair value of Derivatives Liabilities 1,059,000 356,000 (244,000) 367,000
Change in fair value of Warrant Liabilities 17,000 4,410,000
Loss on issuance of Series F-1 Convertible Preferred Stock 3,737,000
Loss on issuance of Series G Convertible Preferred Stock 5,109,000
Casualty Loss/(Gain) (100,000) (100,000)
Total Other (Income)/Expense 1,022,736 103,752 (400,783) 13,315,173
Income/(Loss) Before Income Tax (2,811,388) (1,929,391) (5,732,326) (21,295,080)
Income Tax Benefit/(Provision)
Net Income/(Loss) (2,811,388) (1,929,391) (5,732,326) (21,295,080)
Preferred Stock Dividends 901,902 751,052 2,691,767 2,730,259
Net Income/(Loss) Attributable to Common Stockholders $ (3,713,290) $ (2,680,443) $ (8,424,093) $ (24,025,339)
Basic net loss per common share $ (2.50) $ (107.62) $ (14.77) $ (1,015.18)
Diluted loss per common share $ (2.50) $ (107.62) $ (14.77) $ (1,015.18)
Weighted average basic common stock outstanding 1,483,341 24,907 570,353 23,666
Weighted average diluted common stock outstanding 1,483,341 24,907 570,353 23,666